Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
1226 results
-
2022 influenza vaccination – early advice for vaccination providers
Vaccination against influenza (flu) is important this year. Vaccination is our best defence against flu viruses. -
Top 3 questions – Staying positive, social anxiety, and support for health workers
Deputy Chief Medical Officer, Dr Ruth Vine, answers the top three questions you've been asking on our social accounts around mental health. -
Expressions of interest now open for the COVID-19 pandemic response workforce
The Australian Government is calling on retired, part-time and under-employed health care workers to provide their skills to support the health workforce and the Australian community. Find out how you can get involved. -
ATAGI recommendations on the use of Spikevax (Moderna) COVID-19 vaccine in children aged 6 to 11 years
The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for the use of the Moderna COVID-19 vaccine in children aged 6 to 11 years. -
Soliris® (eculizumab) available on PBS from 1 March 2022
The program that subsidises Soliris® for patients with a rare condition called paroxysmal nocturnal haemoglobinuria (PNH) is changing. Until now, we have subsidised Soliris® under the Life Saving Drugs Program. From 1 March 2022, this will change to the Pharmaceutical Benefits Scheme (PBS). -
COVID-19 vaccination information kiosks open now in NSW, Qld, SA, Vic and WA
COVID-19 vaccination information kiosks are now open in shopping centres New South Wales, Queensland, South Australia, Victoria and Western Australia to help you book a vaccination appointment. -
ATAGI update following weekly COVID-19 meeting – 16 February 2022
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 16 February 2022. -
Hearing Services Program provider notice 2022-03 – Temporary change to service requirements
The Schedule of Service Items and Fees (No. 1) 2022 is now available. Verbal maintenance agreements can be provided. The change to service requirements comes into effect 21 February 2022. -
TGA approval of Moderna's COVID-19 vaccine for people 6 years and older
The Therapeutic Goods Administration (TGA) has provisionally approved the Spikevax (Moderna) vaccine, for people 6 years and older. -
Top 3 COVID-19 vaccine questions – COVID variants & symptoms, body recovery from COVID & Omicron
Dr Lucas de Toca, COVID-19 Primary Care Response First Assistant Secretary, answers the top 3 questions you’ve been asking on our social accounts. -
Why assess MRFF grants? Our Roll of Honour members explain
Have you thought about participating in MRFF grant assessment committees? Read the experiences of our assessors and find out how to nominate. -
COVID-19 vaccination information kiosks open now in Vic, NSW, WA and Qld
COVID-19 vaccination information kiosks are now open in shopping centres and events in New South Wales, Queensland, Victoria and Western Australia to help you book a vaccination appointment. -
Top 3 COVID-19 vaccine questions – Avoiding certain things before a RAT, testing for kids, and variants picked up by tests
Dr Lucas De Toca, COVID-19 Primary Care Response First Assistant Secretary, answers the Top Three questions across our channels. -
Rapid Antigen Tests
A rapid antigen test (RAT) is a quick way to test if you are positive for COVID-19. -
ATAGI update following weekly COVID-19 meeting – 9 February 2022
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 9 February 2022. -
Support for research to reduce pressure on emergency departments
The Australian Government will invest up to $24 million in research to improve acute care systems and reduce emergency department waiting times. Funding is from the Medical Research Future Fund (MRFF). -
Release of the concept paper – Concepts for a new framework for regulating aged care
We have released a concept paper outlining a new, improved approach to regulating aged care. -
ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years
The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years. -
ATAGI update following weekly COVID-19 meeting – 2 February 2022
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 2 February 2022. -
ATAGI update following weekly COVID-19 meeting – 27 January 2022
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 27 January 2022. -
COVID-19 vaccination information kiosks open now in SA, WA, Vic, NSW and Qld
COVID-19 vaccination information kiosks are now open in shopping centres and events in South Australia, Western Australia, Victoria, New South Wales and Queensland to help you book a vaccination appointment. -
Top 3 COVID-19 vaccine questions – Reinfection, cases in vaccinated areas and best masks
Professor Alison McMillan, Chief Nursing and Midwifery Officer, answers the top three questions across our channels. -
Hearing Services Program provider notice 2022-02 – Service requirements in 2022
Providers must comply with all program requirements, including the schedule of services items and fees. Providers must comply with mandatory state and territory Public Health Orders. -
ATAGI update following weekly COVID-19 meeting – 19 January 2022
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 19 January 2022.
-
ATAGI statement on the use of Novavax COVID-19 vaccine (Nuvaxovid)
Novavax COVID-19 vaccine, also known as Nuvaxovid (Biocelect Pty Ltd/Novavax Inc) has been provisionally approved by the Therapeutic Goods Administration (TGA) for use in a primary course of vaccination in people aged 18 years and older.